Le Professeur Yves Lévy, Président-directeur général de l’Inserm.
“It is an immense honour to have been appointed as a member of this international task force by the UN Secretary-General, to fulfil this ambitious mission,” says Yves Lévy, Chairman and CEO of Inserm. “Like the REACTing consortium (REsearch and ACTion targeting emerging infectious diseases), spearheaded by Inserm and Aviesan in 2013 to improve research preparation in periods between crises, and establish research projects in periods of epidemic crisis, I hope our work will contribute to strengthening the systems, throughout the world, that can assist the global response to the emergence of epidemics. It has become a key health issue for the planet.”
The Task Force will exercise its functions for one year, starting in July 2016.
The Task Force will be co-led by Jan Eliasson, UN Deputy Secretary-General, Jim Yong Kim, President of the World Bank Group and Margaret Chan, Director-General of WHO. The Deputy Secretary-General will serve as Chair of the Task Force.
The list of co-leads and members of the Task Force is accessible via the link below:
 This panel was established in April 2015 by Secretary-General Ban Ki-moon to strengthen national and international systems to prevent and manage health crises, taking into account lessons learned from the response to the emergence of Ebola virus in West Africa in early 2015.
Devenir acteur de la recherche pour contribuer à faire avancer les connaissances et trouver de nouveaux traitements est l'un des « leitmotiv » des personnes, malades ou non, qui participent aux essais cliniques. Les volontaires ont toujours joué un rôle capital ...